Pfizer
Developing a Conceptual Framework of Healthcare System Pressure
13 February 2024
The term ‘pressure’ has been widely used to describe various challenges, long before the COVID-19 pandemic. Regardless of its common usage, a formal definition of healthcare system pressure (HCSP) is currently missing.
The Economics of Antibiotics – Part 4: What Does the Antibiotics Market of the Future Look Like?
12 October 2022
In this fourth and final blog in our AMR series, we set out a positive scenario for tackling antibiotic resistance, and contemplate other possibilities.
The Economics of Antibiotics – Part 3: Creating a Healthy Global Market for New Antibiotics
12 October 2022
In the third instalment in our blog series, we think about how the rest of the world can join the effort to stimulate a healthy market for new antibiotics….
The Economics of Antibiotics – Part 2: Value Assessment within the NICE-NHS AMR Pilot
12 October 2022
This second blog focuses on the value assessment used within the NICE-NHS England AMR pilot, which is crucial for capturing an antibiotic’s value so the subscription model can reward those with higher value.
The Economics of Antibiotics – Part 1: Why NICE and NHS England are Testing an Innovative HTA and Payment Model to Tackle Antimicrobial Resistance
12 October 2022
Recently the UK became the first country in the world to test a so-called ‘fully delinked model’ to pay for antibiotics. OHE is publishing a series of four blogs to answer the key questions raised by the NICE-NHS England AMR model [and discuss what it means for the future of antibiotic development].
The Value of Vaccines in Maintaining Health System Capacity in England
1 October 2021
This report has now been published as an article in Value in Health available here. The NHS is facing unprecedented health system pressure, with a record number…
Meningococcal Vaccines: An International Comparison of Decision-Making Processes, Frameworks and Methodologies. Are Values Missing?
3 January 2020
Meningococcal disease is a life-threatening infection and can result in severe sequelae. Recent scientific and technical advances have led to the discovery and implementation of novel…
Assessing Trends in SMC Advice Decisions (October 2009- September 2015)
1 February 2016
The objective of this OHE Consulting Report was to outline trends in Scottish Medicines Committee (SMC) advice decisions for medicines for the period October 2009 to…